Regen Biopharma (RGBP) Stock Statistics & Valuation Metrics

Regen Biopharma has a market cap or net worth of $143.53K. The enterprise value is $970.96K.

Regen Biopharma has 1,435,277,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Regen Biopharma’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 6.19%.

The current PE Ratio of Regen Biopharma is ―. Regen Biopharma’s PEG ratio is 0.00377.

In the last 12 months, Regen Biopharma had revenue of 236.56K and earned -1.27M in profits. Earnings per share was -0.05.

In the last 12 months, operating cash flow was -445.25K and capital expenditures 3.00, giving a free cash flow of -445.25K billion.

Regen Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―

Regen Biopharma upcoming earnings date is May 14, 2018, Before Open (Confirmed).

Regen Biopharma as a current ratio of 0.04, with Debt / Equity ratio of -15.73%

In the past 12 months, Regen Biopharma has paid 0.00 in taxes.

Regen Biopharma EV to EBITDA ratio is -1.10, with an EV/FCF ratio of -2.90.

Regen Biopharma has $239.00 in cash and marketable securities with $924.72K in debt, giving a net cash position of -$924.48K billion.

Gross margin is 75.03%, with operating margin of -143.11%, and net profit margin of -538.76%.

The average price target for Regen Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―